Table 2.

Characteristics of patients with acute post-IVI endophthalmitis in pre-COVID and COVID periods

No	Period	Age	Gender	Dx	Injection type	No of prior IV injections	Injected eye	Time to presentation (days)	VA before injection	VA at admission	VA at discharge	Management	Culture	Facial mask
1	Pre-COVID	62	M	DME	IVB + IVT	7	OU	9	0.10	HM	CF3m	Primary PPV	No Growth	No
2	Pre-COVID	70	M	AMD	IVB	0	OD	3	0.3	HM	HM	IVAB then PPV	CONS	No
3	Pre-COVID	72	F	DME	IVB	5	OS	1	CF3m	CF30cm	CF30cm	IVAB	No Growth	No
4	Pre-COVID	72	M	DME	IVB	6	OS	8	CF	HM	CF50cm	IVAB	No Growth	No
5	Pre-COVID	67	F	DME	IVB	8	OU	3	0.1	0.1	LP	IVAB then PPV	CONS *	No
6	Pre-COVID	51	F	DME	IVB	1	OU	4	CF	LP	LP	Primary PPV	CONS	No
7	Pre-COVID	90	M	AMD	IVB	3	OS	4	CF	LP	CF10cm	IVAB then PPV	CONS	No
8	COVID	74	M	AMD	IVB	13	OU	3	CF	HM	LP	Primary PPV	CONS *	Yes
9	COVID	51	F	BRVO	IVB	8	OD	5	CF	HM	HM	IVAB then PPV	CONS	Yes
10	COVID	87	M	AMD	IVB	5	OS	7	CF	HM	CF50cm	IVAB	No Growth	Yes
11	COVID	54	F	DME	IVB	7	OU	3	CF	HM	HM	IVAB then PPV	CONS	Yes
12	COVID	54	F	DME	IVB	7	OU	4	0.4	HM	CF50cm	Primary PPV	CONS	Yes
13	COVID	86	M	AMD	IVB	1	OD	24	CF	LP	LP	IVAB	CONS *	Yes
14	COVID	41	M	BRVO	IVB	1	OD	3	CF	CF50cm	CF20cm	IVAB then PPV	CONS *	Yes

AMD age-related macular degeneration, BRVO branch retinal vein occlusion, CONS coagulase-negative staphylococcus, DME diabetic macular edema, Dx diagnosis, CF counting finger, HM hand motion, IV intravitreal, IVAB intravitreal antibiotic, IVB intravitreal bevacizumab, IVT intravitreal triamcinolone, LP light perception, PPV pars plana vitrectomy. *Methicillin-resistant coagulase negative Staphylococcus